|
Volumn 16, Issue 6, 2009, Pages 4927-4931
|
Intravesical therapy use in the high risk patient: practice patterns in an equal access healthcare institution before and after national guidelines.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
IMMUNOLOGICAL ADJUVANT;
ARTICLE;
BIOPSY;
BLADDER TUMOR;
CLINICAL COMPETENCE;
COMPARATIVE STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
INCIDENCE;
INTRAVESICAL DRUG ADMINISTRATION;
MALE;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
RISK FACTOR;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
UNITED STATES;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
BCG VACCINE;
BIOPSY;
CLINICAL COMPETENCE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
NEOPLASM RECURRENCE, LOCAL;
PRACTICE GUIDELINES AS TOPIC;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
URINARY BLADDER NEOPLASMS;
|
EID: 77956206887
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|